Financials Cronos Group Inc. Nasdaq

Equities

CRON

CA22717L1013

Pharmaceuticals

Market Closed - Nasdaq 21:00:00 10/05/2024 BST 5-day change 1st Jan Change
2.77 USD -2.81% Intraday chart for Cronos Group Inc. +3.36% +32.54%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,477 3,145 1,859 1,304 1,056 1,452 - -
Enterprise Value (EV) 1 1,348 3,145 583.8 109.9 -113.6 264.6 260.6 1,452
P/E ratio 2.12 x -33.6 x -3.67 x -5.62 x -10.7 x -99.3 x -328 x 438 x
Yield - - - - - - - -
Capitalization / Revenue 104 x 53.8 x 19.7 x 10.4 x 8.92 x 10.3 x 8.6 x 7.91 x
EV / Revenue 40.1 x 53.8 x 6.18 x 0.88 x -0.96 x 1.88 x 1.54 x 7.91 x
EV / EBITDA -8.64 x -17.1 x -2.87 x -1 x 1.31 x -4.84 x -9.65 x -57.7 x
EV / FCF -5.65 x -14.2 x -2.79 x -0.87 x 1.85 x -32.9 x -14.6 x -72.8 x
FCF Yield -17.7% -7.02% -35.8% -114% 54.2% -3.04% -6.87% -1.37%
Price to Book 1.41 x - - - - - - -
Nbr of stocks (in thousands) 348,782 355,773 373,287 379,095 381,114 382,011 - -
Reference price 2 9.970 8.840 4.980 3.440 2.770 3.800 3.800 3.800
Announcement Date 30/03/20 26/02/21 01/03/22 28/02/23 29/02/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 33.58 58.47 94.48 125 118.4 140.6 168.8 183.5
EBITDA 1 -156 -184.3 -203.7 -109.7 -86.52 -54.63 -27 -25.18
EBIT 1 -161.5 -224.4 -711.5 -169.9 -115.1 -81.58 -50.94 -34.16
Operating Margin -480.91% -383.88% -753.13% -135.84% -97.2% -58.03% -30.17% -18.62%
Earnings before Tax (EBT) 1 1,648 -91.7 -504.1 -183.1 -99.99 -17.97 11.15 8.904
Net income 1 1,649 -91.53 -502.8 -229.6 -100.4 -17.49 7.758 5.543
Net margin 4,911.6% -156.55% -532.15% -183.6% -84.78% -12.44% 4.6% 3.02%
EPS 2 4.708 -0.2628 -1.358 -0.6123 -0.2579 -0.0383 -0.0116 0.008670
Free Cash Flow 1 -238.5 -220.8 -209.1 -125.7 -61.54 -8.036 -17.9 -19.93
FCF margin -710.19% -377.68% -221.35% -100.54% -51.97% -5.72% -10.6% -10.86%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 30/03/20 26/02/21 01/03/22 28/02/23 29/02/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 32.74 32.51 29.62 28.28 31.14 26.91 25.45 34.23 32.46 34.61 35.93 35.52 37.24 41.4 42.22
EBITDA 1 -34.72 -24.55 -24.14 -29.32 -28.86 -22.39 -21.28 -20.95 -19.98 -14.6 -10.44 -9.274 -7.786 -2.836 -3.292
EBIT 1 -206.4 -46.82 -36.04 -41.9 -40.43 -29.38 -27.59 -30.04 -29.36 -21.82 -21.46 -19.52 -18.2 -8.413 -8.895
Operating Margin -630.49% -144.01% -121.7% -148.18% -129.85% -109.19% -108.41% -87.77% -90.47% -63.07% -59.73% -54.95% -48.87% -20.32% -21.07%
Earnings before Tax (EBT) 1 -170.3 -41.94 -26.51 -46.99 -63.75 -27.64 -7.817 -3.924 -61.77 -4.163 -3.011 1.095 1.505 19.3 10.67
Net income 1 -169.6 -42.39 -25.97 -49.99 -107.3 -25.6 -11.19 -2.268 -60.79 -3.067 -2.798 -0.5626 -1.372 11.14 9.305
Net margin -518.07% -130.38% -87.68% -176.8% -344.67% -95.16% -43.95% -6.63% -187.29% -8.86% -7.79% -1.58% -3.69% 26.9% 22.04%
EPS 2 -0.4569 -0.1169 -0.0642 -0.1352 -0.2857 -0.0668 -0.0268 - -0.1629 -0.0137 -0.003420 -0.003420 0.000080 0.0273 0.0270
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 01/03/22 10/05/22 09/08/22 07/11/22 28/02/23 09/05/23 08/08/23 08/11/23 29/02/24 09/05/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 2,129 - 1,275 1,194 1,169 1,187 1,191 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -238 -221 -209 -126 -61.5 -8.04 -17.9 -19.9
ROE (net income / shareholders' equity) 66.7% -4.23% -26% -13.6% -2.29% -1.83% -4.7% -3.3%
ROA (Net income/ Total Assets) 103% -3.64% -23.8% -12.9% -2.17% -2.7% -4.5% -3.1%
Assets 1 1,608 2,513 2,109 1,776 4,621 647.8 -172.4 -178.8
Book Value Per Share 7.090 - - - - - - -
Cash Flow per Share 2 -0.5400 -0.5100 -0.5300 -0.3200 -0.1500 0.1400 0.0800 -0.0400
Capex 1 55.1 39.9 14.1 4.7 3.4 5.79 4.76 5.25
Capex / Sales 164.01% 68.23% 14.97% 3.76% 2.87% 4.12% 2.82% 2.86%
Announcement Date 30/03/20 26/02/21 01/03/22 28/02/23 29/02/24 - - -
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.8 CAD
Average target price
3.696 CAD
Spread / Average Target
-2.74%
Consensus
  1. Stock Market
  2. Equities
  3. CRON Stock
  4. CRON Stock
  5. Financials Cronos Group Inc.